Cargando…
Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845115/ https://www.ncbi.nlm.nih.gov/pubmed/26475299 http://dx.doi.org/10.1161/JAHA.115.001991 |
| _version_ | 1782428882469650432 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4845115 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48451152016-04-27 Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects J Am Heart Assoc Correction John Wiley and Sons Inc. 2015-10-16 /pmc/articles/PMC4845115/ /pubmed/26475299 http://dx.doi.org/10.1161/JAHA.115.001991 Text en © 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Correction Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects |
| title | Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects |
| title_full | Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects |
| title_fullStr | Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects |
| title_full_unstemmed | Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects |
| title_short | Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects |
| title_sort | effect of bromocriptine‐qr (a quick‐release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845115/ https://www.ncbi.nlm.nih.gov/pubmed/26475299 http://dx.doi.org/10.1161/JAHA.115.001991 |